Invasive Group A Streptococcal Infection

ConditionsSepsis Due to Streptococcus, Group A Risk Factors Severe Infection Medical Care Medical Complications Outcome, Fatal Therapy Strain Virulence Factors

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-17

SponsorAssociation Clinique Thérapeutique Infantile du val de Marne

About this trial

This study is observational, retrospective and prospective study in pediatric patients hospitalized with invasive streptococcal A infection

Eligibility criteria

Qualifiers

Age<18 years

Documented invasive Group A Streptococcus infection (identification of GAS in a normally sterile site or from another site in case of toxin shock or necrotizing dermo-hypodermatitis)

Disqualifiers

Opposition of the patient or his/her legal representative

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations

ACTIV94000, Créteil France

Sponsors and collaborators

Association Clinique Thérapeutique Infantile du val de Marne

Lead sponsor

Source ClinicalTrials.gov